These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 12128051)
1. Trypanosoma cruzi: methoprene is a potent agent to sterilize blood infected with trypomastigotes. Esteva M; Ruiz AM; Stoka AM Exp Parasitol; 2002 Apr; 100(4):248-51. PubMed ID: 12128051 [TBL] [Abstract][Full Text] [Related]
2. Effects of juvenile hormone analogues (JHA) on the development of Trypanosoma cruzi. Fichera L; Esteva M; Wimmer Z; Rodriguez JB; Gros EG Z Naturforsch C J Biosci; 1995; 50(7-8):578-80. PubMed ID: 7546047 [TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect. Arantes JM; Francisco AF; de Abreu Vieira PM; Silva M; Araújo MS; de Carvalho AT; Pedrosa ML; Carneiro CM; Tafuri WL; Martins-Filho OA; Elói-Santos SM Exp Parasitol; 2011 Aug; 128(4):401-8. PubMed ID: 21620835 [TBL] [Abstract][Full Text] [Related]
4. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice. Barr SC; Rose D; Jaynes JM J Parasitol; 1995 Dec; 81(6):974-8. PubMed ID: 8544074 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models. Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors. Silva JJ; Osakabe AL; Pavanelli WR; Silva JS; Franco DW Br J Pharmacol; 2007 Sep; 152(1):112-21. PubMed ID: 17603548 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo trypanocidal activity of a benzofuroxan derivative against Trypanosoma cruzi. Dos Santos Petry L; Pillar Mayer JC; de Giacommeti M; Teixeira de Oliveira D; Razia Garzon L; Martiele Engelmann A; Magalhães de Matos AFI; Dellaméa Baldissera M; Dornelles L; Melazzo de Andrade C; Gonzalez Monteiro S Exp Parasitol; 2021; 226-227():108125. PubMed ID: 34129877 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi. Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938 [TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi. Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830 [TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi: chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area. Rivarola HW; Bustamante JM; Lo Presti S; Fernández AR; Enders JE; Gea S; Fretes R; Paglini-Oliva P Exp Parasitol; 2005 Oct; 111(2):80-6. PubMed ID: 16085036 [TBL] [Abstract][Full Text] [Related]
12. Santos CC; Lionel JR; Peres RB; Batista MM; da Silva PB; de Oliveira GM; da Silva CF; Batista DGJ; Souza SMO; Andrade CH; Neves BJ; Braga RC; Patrick DA; Bakunova SM; Tidwell RR; Soeiro MNC Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203486 [TBL] [Abstract][Full Text] [Related]
13. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection. Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038 [TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg). Güida MC; Esteva MI; Camino A; Flawiá MM; Torres HN; Paveto C Exp Parasitol; 2007 Oct; 117(2):188-94. PubMed ID: 17673202 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach. Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395 [TBL] [Abstract][Full Text] [Related]
16. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease. García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322 [TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection. Fernández MC; González Cappa SM; Solana ME Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482 [TBL] [Abstract][Full Text] [Related]
18. Activity of juvenile hormone and juvenile hormone analogues on the growth of Trypanosoma cruzi. Stoka AM J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):495-500. PubMed ID: 9010355 [TBL] [Abstract][Full Text] [Related]
19. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target. Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250 [TBL] [Abstract][Full Text] [Related]
20. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase. Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]